Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ChemoCentryx, Inc. (CCXI)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Cost of goods sold | 503.2% | 185.0% | 261.4% | 0.0% | 0.0% | 0.0% | | |
| Gross profit | -403.2% | -85.0% | -161.4% | 100.0% | 100.0% | 100.0% | | |
| Selling, general and administrative | 0.0% | 0.0% | 0.0% | | | | | |
| Research and development | | | | 146.3% | 60.0% | 317.9% | | |
| General and administrative | 0.0% | 0.0% | 0.0% | 47.6% | 20.0% | 123.3% | | |
| Depreciation | | | | 1.2% | 0.5% | 2.9% | | |
| EBIT | -395.4% | -83.0% | -157.7% | -93.9% | 20.0% | -341.2% | | |
| Pre-tax income | -408.9% | -85.3% | -153.6% | -88.6% | 21.6% | -334.8% | | |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | |
| Net income | -408.9% | -85.3% | -153.6% | -88.6% | 21.6% | -334.8% | | |
|